HEALTHY MINDS with Dr. Jeffrey Borenstein
Program Rights Date Range
-
NOLA Code:
HMJB 0700 H1
Number of Episodes/Length:
11 / 30
Genre:
Collections:
Rights End:
5/1/2025
Producer
The Brain and Behavior Foundation
Presenter
Connecticut Public Television
SAP:
Year Produced:
2022
Version:
Base
Removing the stigma of mental illness.
Episode List
#701 How Covid-19 Affects the Brain
Researchers are discovering how COVID-19 affects the brain in the short and long term, including brain fog, depression, anxiety, and increased risk of suicide. Maura Boldrini, M.D., Ph.D., Associate Professor of Psychiatry at Columbia Medical College and Director of the Human Brain Biology Institute (Brain QUANT) at Columbia University Irving Medical Center discusses the latest developments including the difference vaccination makes in decreasing the risk of brain impact.
250 character: (213)
Researchers are discovering how COVID-19 affects the brain in the short and long term, including brain fog, depression, anxiety, and increased risk of suicide; how vaccination decreases the risk of brain impact.
100 character: (101)
COVID-19’s effect on the brain includes brain fog, depression, anxiety, increased risk of suicide.
#702 National Institute of Mental Health: An Update on Promising Research
Joshua A. Gordon, M.D., Ph.D. the Director of the National Institute of Mental Health (NIMH), the lead federal agency for research on mental disorders, gives an update on promising new research currently underway.
250 character: (214)
Joshua A. Gordon, M.D., Ph.D. the Director of the National Institute of Mental Health (NIMH), the lead federal agency for research on mental disorders, gives an update on promising new research currently underway.
100 character: (100)
The Director of the National Institute of Mental Health gives an update on promising new research.
#703 Rapid-Acting Transcranial Magnetic Stimulation
The new rapid-acting Transcranial Magnetic Stimulation therapy for treatment-resistant depression works in days instead of weeks, and may have implications for use in other mental disorders. Nolan Williams, M.D., Assistant Professor, Director, Interventional Psychiatry Clinical Research and Director, Brain Stimulation Laboratory at the Department of Psychiatry and Behavioral Sciences Stanford University Medical Center explains how this non-invasive treatment works.
250 character: (205)
The new rapid-acting non-invasive Transcranial Magnetic Stimulation therapy for treatment-resistant depression works in days instead of weeks, and may have implications for use in other mental disorders.
100 character:(78)
A treatment that works in days instead of weeks offers new hope for depression.
#704 Optogenetics with Karl Deisseroth, M.D., Ph.D. - Part One
A technique that uses light to control brain cells enables researchers to turn behaviors on and off in lab mice to better understand the human brain and disorders including autism, depression, eating disorders, and more. Karl Deisseroth, M.D., Ph.D, professor of Bioengineering, Psychiatry and Behavioral Sciences at Stanford University’s Howard Hughes Medical Institute, developed optogenetics and explains his research and how his findings impact what he sees clinically working with human patients.
250 character: (223)
Using light to control brain cells enables researchers to turn behaviors on and off in lab mice, which may help them better understand the human brain and mental disorders including autism, depression, and eating disorders.
100 character: (98)
Using light to control brain cells in lab mice to better understand the human brain and disorders.
#705 Optogenetics with Karl Deisseroth M.D., Ph.D. - Part Two
Dr. Borenstein continues his conversation with Karl Deisseroth, M.D., Ph.D, professor of Bioengineering, Psychiatry and Behavioral Sciences at Stanford University’s Howard Hughes Medical Institute, about his revolutionary optogenetics research of behavior in mice that can help doctors better understand the human brain and disorders.
250 Character: (191)
Dr. Borenstein continues his conversation with Dr. Karl Deisseroth about his revolutionary optogenetics research and its potential for understanding how the human brain processes information.
100 characters:(96)
Dr. Karl Deisseroth’s revolutionary optogenetics offers a new way to understand how brains work.
#706 Deep Brain Stimulation - Treatment-Resistant Depression
A treatment originally used for Parkinson’s Disease may have the potential to help patients with depression who have not responded to multiple treatments including medications, psychotherapy, and electroconvulsive therapy. Helen Mayberg, M.D, Professor of Neurology, Neurosurgery, Psychiatry, and Neuroscience Icahn School of Medicine Mount Sinai and Director, Center for Advanced Circuit Therapeutics, Icahn School of Medicine Mount Sinai, discusses the next generation of deep brain stimulation (DBS).
250 character:(201)
A treatment originally used for Parkinson’s Disease may have the potential to help patients with depression who have not responded to multiple medications, psychotherapy, and electroconvulsive therapy.
100 character: (100)
A treatment originally used for Parkinson’s may have the potential to help patients with depression.
#707 Psychedelic-Assisted Psychotherapy and Post-Traumatic Stress
New uses for psychedelic drugs offer potential breakthroughs for patients with post-traumatic stress, working with trained therapists to guide the experience and open perspectives into a patient’s state of mind. Rachel Yehuda, Ph.D., Professor of Psychiatry and Neuroscience / Icahn School of Medicine in Mount Sinai and Director, Center for Psychedelic Psychotherapy and Trauma Research has been at the forefront of trauma research for three decades and discusses this new development.
250 character: (211)
New uses for psychedelic drugs offer potential breakthroughs for patients with post-traumatic stress, working with trained therapists to guide the experience and open perspectives into a patient’s state of mind.
100 character: (104)
A guided experience with therapists using psychedelics may offer insight into a patient’s state of mind.
#708 Bipolar Disorder, What You And Your Family Need To Know
Exploring the symptoms, warning signs, and early treatment options for adolescents and young adults with bipolar disorder. David J. Miklowitz, Ph.D., Distinguished Professor of Psychiatry at UCLA Semel Institute, takes families through the vital information they may need.
250 character: (160)
Vital information for families to recognize the symptoms, warning signs of bipolar disorder in adolescents and young adults, and options for early treatment..
100 character: (101)
Symptoms, warning signs, and early treatment for adolescents and young adults with bipolar disorder.
#709 Living With Bipolar: A Conversation with Maurice Benard
Emmy Award-winning actor Maurice Benard shares his experience living with bipolar disorder, and his work as an advocate for awareness to remove stigma, which included his character Sonny Corinthos on the soap opera General Hospital sharing his disorder.
250 character: (235)
Actor Maurice Benard shares his experience living with bipolar disorder, and his work as an advocate for awareness to remove stigma, which included his character “Sonny Corinthos” on the soap opera General Hospital sharing his disorder.
100 character: (101)
Actor Maurice Benard shares his experience living with bipolar disorder, and his work as an advocate.
#710 Managing a Mental Health Crisis and the New # 988
The nationwide rollout of the “9-8-8” mental health crisis emergency number in July 2022 provides an alternative response chain for mental health-related crises. William H. Carson, M.D., Chairman of the Sozosei Foundation explains how mental health and suicide prevention services will be responded to in ways that 9-1-1 calls aren’t able to handle.
250 characters: (214)
The nationwide rollout of the “9-8-8” mental health crisis emergency number in July 2022 provides an alternative response chain for mental health-related crises for a type of care 9-1-1 calls aren’t able to handle.
100 characters: (101)
The “9-8-8” emergency number provides an alternative response chain for mental health-related crises.
#711 Depression - Intersection of Faith and Mental Health
A psychologist who lost his daughter to suicide has become a leading voice of support for others, sharing how his faith, clinical training, and his own depression impacted his experience. W. Daniel Hale,, Ph.D, Special Advisor to the President of Johns Hopkins Bayview Medical Center, offers insight for families to try to help them prevent their own tragedy.
250 characters: (188)
A psychologist who lost his daughter to suicide has become a leading voice of support for others, sharing how his faith, clinical training, and his own depression impacted his experience.
100 characters: (98)
A psychologist who lost his daughter to suicide has become a leading voice of support for others.
Researchers are discovering how COVID-19 affects the brain in the short and long term, including brain fog, depression, anxiety, and increased risk of suicide. Maura Boldrini, M.D., Ph.D., Associate Professor of Psychiatry at Columbia Medical College and Director of the Human Brain Biology Institute (Brain QUANT) at Columbia University Irving Medical Center discusses the latest developments including the difference vaccination makes in decreasing the risk of brain impact.
250 character: (213)
Researchers are discovering how COVID-19 affects the brain in the short and long term, including brain fog, depression, anxiety, and increased risk of suicide; how vaccination decreases the risk of brain impact.
100 character: (101)
COVID-19’s effect on the brain includes brain fog, depression, anxiety, increased risk of suicide.
#702 National Institute of Mental Health: An Update on Promising Research
Joshua A. Gordon, M.D., Ph.D. the Director of the National Institute of Mental Health (NIMH), the lead federal agency for research on mental disorders, gives an update on promising new research currently underway.
250 character: (214)
Joshua A. Gordon, M.D., Ph.D. the Director of the National Institute of Mental Health (NIMH), the lead federal agency for research on mental disorders, gives an update on promising new research currently underway.
100 character: (100)
The Director of the National Institute of Mental Health gives an update on promising new research.
#703 Rapid-Acting Transcranial Magnetic Stimulation
The new rapid-acting Transcranial Magnetic Stimulation therapy for treatment-resistant depression works in days instead of weeks, and may have implications for use in other mental disorders. Nolan Williams, M.D., Assistant Professor, Director, Interventional Psychiatry Clinical Research and Director, Brain Stimulation Laboratory at the Department of Psychiatry and Behavioral Sciences Stanford University Medical Center explains how this non-invasive treatment works.
250 character: (205)
The new rapid-acting non-invasive Transcranial Magnetic Stimulation therapy for treatment-resistant depression works in days instead of weeks, and may have implications for use in other mental disorders.
100 character:(78)
A treatment that works in days instead of weeks offers new hope for depression.
#704 Optogenetics with Karl Deisseroth, M.D., Ph.D. - Part One
A technique that uses light to control brain cells enables researchers to turn behaviors on and off in lab mice to better understand the human brain and disorders including autism, depression, eating disorders, and more. Karl Deisseroth, M.D., Ph.D, professor of Bioengineering, Psychiatry and Behavioral Sciences at Stanford University’s Howard Hughes Medical Institute, developed optogenetics and explains his research and how his findings impact what he sees clinically working with human patients.
250 character: (223)
Using light to control brain cells enables researchers to turn behaviors on and off in lab mice, which may help them better understand the human brain and mental disorders including autism, depression, and eating disorders.
100 character: (98)
Using light to control brain cells in lab mice to better understand the human brain and disorders.
#705 Optogenetics with Karl Deisseroth M.D., Ph.D. - Part Two
Dr. Borenstein continues his conversation with Karl Deisseroth, M.D., Ph.D, professor of Bioengineering, Psychiatry and Behavioral Sciences at Stanford University’s Howard Hughes Medical Institute, about his revolutionary optogenetics research of behavior in mice that can help doctors better understand the human brain and disorders.
250 Character: (191)
Dr. Borenstein continues his conversation with Dr. Karl Deisseroth about his revolutionary optogenetics research and its potential for understanding how the human brain processes information.
100 characters:(96)
Dr. Karl Deisseroth’s revolutionary optogenetics offers a new way to understand how brains work.
#706 Deep Brain Stimulation - Treatment-Resistant Depression
A treatment originally used for Parkinson’s Disease may have the potential to help patients with depression who have not responded to multiple treatments including medications, psychotherapy, and electroconvulsive therapy. Helen Mayberg, M.D, Professor of Neurology, Neurosurgery, Psychiatry, and Neuroscience Icahn School of Medicine Mount Sinai and Director, Center for Advanced Circuit Therapeutics, Icahn School of Medicine Mount Sinai, discusses the next generation of deep brain stimulation (DBS).
250 character:(201)
A treatment originally used for Parkinson’s Disease may have the potential to help patients with depression who have not responded to multiple medications, psychotherapy, and electroconvulsive therapy.
100 character: (100)
A treatment originally used for Parkinson’s may have the potential to help patients with depression.
#707 Psychedelic-Assisted Psychotherapy and Post-Traumatic Stress
New uses for psychedelic drugs offer potential breakthroughs for patients with post-traumatic stress, working with trained therapists to guide the experience and open perspectives into a patient’s state of mind. Rachel Yehuda, Ph.D., Professor of Psychiatry and Neuroscience / Icahn School of Medicine in Mount Sinai and Director, Center for Psychedelic Psychotherapy and Trauma Research has been at the forefront of trauma research for three decades and discusses this new development.
250 character: (211)
New uses for psychedelic drugs offer potential breakthroughs for patients with post-traumatic stress, working with trained therapists to guide the experience and open perspectives into a patient’s state of mind.
100 character: (104)
A guided experience with therapists using psychedelics may offer insight into a patient’s state of mind.
#708 Bipolar Disorder, What You And Your Family Need To Know
Exploring the symptoms, warning signs, and early treatment options for adolescents and young adults with bipolar disorder. David J. Miklowitz, Ph.D., Distinguished Professor of Psychiatry at UCLA Semel Institute, takes families through the vital information they may need.
250 character: (160)
Vital information for families to recognize the symptoms, warning signs of bipolar disorder in adolescents and young adults, and options for early treatment..
100 character: (101)
Symptoms, warning signs, and early treatment for adolescents and young adults with bipolar disorder.
#709 Living With Bipolar: A Conversation with Maurice Benard
Emmy Award-winning actor Maurice Benard shares his experience living with bipolar disorder, and his work as an advocate for awareness to remove stigma, which included his character Sonny Corinthos on the soap opera General Hospital sharing his disorder.
250 character: (235)
Actor Maurice Benard shares his experience living with bipolar disorder, and his work as an advocate for awareness to remove stigma, which included his character “Sonny Corinthos” on the soap opera General Hospital sharing his disorder.
100 character: (101)
Actor Maurice Benard shares his experience living with bipolar disorder, and his work as an advocate.
#710 Managing a Mental Health Crisis and the New # 988
The nationwide rollout of the “9-8-8” mental health crisis emergency number in July 2022 provides an alternative response chain for mental health-related crises. William H. Carson, M.D., Chairman of the Sozosei Foundation explains how mental health and suicide prevention services will be responded to in ways that 9-1-1 calls aren’t able to handle.
250 characters: (214)
The nationwide rollout of the “9-8-8” mental health crisis emergency number in July 2022 provides an alternative response chain for mental health-related crises for a type of care 9-1-1 calls aren’t able to handle.
100 characters: (101)
The “9-8-8” emergency number provides an alternative response chain for mental health-related crises.
#711 Depression - Intersection of Faith and Mental Health
A psychologist who lost his daughter to suicide has become a leading voice of support for others, sharing how his faith, clinical training, and his own depression impacted his experience. W. Daniel Hale,, Ph.D, Special Advisor to the President of Johns Hopkins Bayview Medical Center, offers insight for families to try to help them prevent their own tragedy.
250 characters: (188)
A psychologist who lost his daughter to suicide has become a leading voice of support for others, sharing how his faith, clinical training, and his own depression impacted his experience.
100 characters: (98)
A psychologist who lost his daughter to suicide has become a leading voice of support for others.
Program Rights
Broadcast Rights:
Unlimited
Rights Dates:
5/2/2022 - 5/1/2025
School Rights:
1 year
V.O.D. Rights:
Yes
V.O.D. Rights Type:
Concurrent w/broadcast rights
Linear Live Streaming:
Yes
Non-Commercial Cable Rights:
Yes
Program Contacts
Contact Type
Viewer
Connecticut Public Audience Care
United States